Abstract:Key PointsInflammatory cytokines, in particular IL-1β, are the key mediators of gouty inflammationThe NLRP3 inflammasome is the major pathway by which MSU crystals trigger the cellular inflammatory responseMultiple regulatory pathways modulate the activity of the inflammasome and the release of IL-1β; this may explain in part the clinical origins of gouty inflammationDiet influences hyperuricaemia as well as the inflammatory state of macrophages in goutNutrients can modulate inflammasome activity and IL-1β release and participate in the regulation of pro-inflammatory as well as anti-inflammatory pathways in goutThe resolution of gouty inflammation is regulated at the cellular level as well as at the level of activation of the inflammasome; these pathways provide promising new avenues for therapeutic intervention

Inflammation in gout: mechanisms and therapeutic targets